Immunomodulatory Drugs in the Management of SARS-CoV-2

With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrage, Daniel R., Koushesh, Soraya, Sofat, Nidhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438578/
https://www.ncbi.nlm.nih.gov/pubmed/32903555
http://dx.doi.org/10.3389/fimmu.2020.01844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438578/
https://www.ncbi.nlm.nih.gov/pubmed/32903555
http://dx.doi.org/10.3389/fimmu.2020.01844

Ejemplares similares